Condition: Acute Myeloid Leukemia · NPM1 Mutation · Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
This is a multicenter observational study with a retrospective and a prospective cohort investigating clinically and biologically the APL-like subset as a potential predictor of coagulopathy and susceptibility to early vascular events.
This description comes directly from the study's public registry record.
Paola Fazi · 0670390528 · p.fazi@gimema.it
Enrico Crea · 0670390514 · e.crea@gimema.it
Always discuss trial participation with your own doctor first.
| SOD Ematologia, Università di Firenze, AOU Careggi | Florence, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07080970